Literature DB >> 20592072

Nonintegrating foamy virus vectors.

David R Deyle1, Yi Li, Erik M Olson, David W Russell.   

Abstract

Foamy viruses (FVs), or spumaviruses, are integrating retroviruses that have been developed as vectors. Here we generated nonintegrating foamy virus (NIFV) vectors by introducing point mutations into the highly conserved DD35E catalytic core motif of the foamy virus integrase sequence. NIFV vectors produced high-titer stocks, transduced dividing cells, and did not integrate. Cells infected with NIFV vectors contained episomal vector genomes that consisted of linear, 1-long-terminal-repeat (1-LTR), and 2-LTR circular DNAs. These episomes expressed transgenes, were stable, and became progressively diluted in the dividing cell population. 1-LTR circles but not 2-LTR circles were found in all vector stocks prior to infection. Residual integration of NIFV vectors occurred at a frequency 4 logs lower than that of integrase-proficient FV vectors. Cre recombinase expressed from a NIFV vector mediated excision of both an integrated, floxed FV vector and a gene-targeted neo expression cassette, demonstrating the utility of these episomal vectors. The broad host range and large packaging capacity of NIFV vectors should make them useful for a variety of applications requiring transient gene expression.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20592072      PMCID: PMC2937610          DOI: 10.1128/JVI.00394-10

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  62 in total

1.  A quantitative assay for HIV DNA integration in vivo.

Authors:  S L Butler; M S Hansen; F D Bushman
Journal:  Nat Med       Date:  2001-05       Impact factor: 53.440

2.  Capture of DNA sequences at double-strand breaks in mammalian chromosomes.

Authors:  Y Lin; A S Waldman
Journal:  Genetics       Date:  2001-08       Impact factor: 4.562

3.  Role of the non-homologous DNA end joining pathway in the early steps of retroviral infection.

Authors:  L Li; J M Olvera; K E Yoder; R S Mitchell; S L Butler; M Lieber; S L Martin; F D Bushman
Journal:  EMBO J       Date:  2001-06-15       Impact factor: 11.598

4.  Transduction of human NOD/SCID-repopulating cells with both lymphoid and myeloid potential by foamy virus vectors.

Authors:  Neil C Josephson; George Vassilopoulos; Grant D Trobridge; Greg V Priestley; Brent L Wood; Thalia Papayannopoulou; David W Russell
Journal:  Proc Natl Acad Sci U S A       Date:  2002-06-11       Impact factor: 11.205

5.  Multiple integrations of human foamy virus in persistently infected human erythroleukemia cells.

Authors:  C D Meiering; K E Comstock; M L Linial
Journal:  J Virol       Date:  2000-02       Impact factor: 5.103

6.  Gene transfer into murine hematopoietic stem cells with helper-free foamy virus vectors.

Authors:  G Vassilopoulos; G Trobridge; N C Josephson; D W Russell
Journal:  Blood       Date:  2001-08-01       Impact factor: 22.113

7.  Critical factors influencing stable transduction of human CD34(+) cells with HIV-1-derived lentiviral vectors.

Authors:  D L Haas; S S Case; G M Crooks; D B Kohn
Journal:  Mol Ther       Date:  2000-07       Impact factor: 11.454

8.  Comparison of three retroviral vector systems for transduction of nonobese diabetic/severe combined immunodeficiency mice repopulating human CD34+ cord blood cells.

Authors:  Cordula Leurs; Michael Jansen; Karen E Pollok; Martin Heinkelein; Manfred Schmidt; Manuela Wissler; Dirk Lindemann; Christof Von Kalle; Axel Rethwilm; David A Williams; Helmut Hanenberg
Journal:  Hum Gene Ther       Date:  2003-04-10       Impact factor: 5.695

9.  Improved foamy virus vectors with minimal viral sequences.

Authors:  Grant Trobridge; Neil Josephson; George Vassilopoulos; Jaclynn Mac; David W Russell
Journal:  Mol Ther       Date:  2002-09       Impact factor: 11.454

10.  Stable gene transfer to muscle using non-integrating lentiviral vectors.

Authors:  Luis Apolonia; Simon N Waddington; Carolina Fernandes; Natalie J Ward; Gerben Bouma; Michael P Blundell; Adrian J Thrasher; Mary K Collins; Nicola J Philpott
Journal:  Mol Ther       Date:  2007-08-14       Impact factor: 11.454

View more
  8 in total

1.  Prototype foamy virus protease activity is essential for intraparticle reverse transcription initiation but not absolutely required for uncoating upon host cell entry.

Authors:  Sylvia Hütter; Erik Müllers; Nicole Stanke; Juliane Reh; Dirk Lindemann
Journal:  J Virol       Date:  2013-01-02       Impact factor: 5.103

2.  Normal collagen and bone production by gene-targeted human osteogenesis imperfecta iPSCs.

Authors:  David R Deyle; Iram F Khan; Gaoying Ren; Pei-Rong Wang; Jordan Kho; Ulrike Schwarze; David W Russell
Journal:  Mol Ther       Date:  2011-10-25       Impact factor: 11.454

3.  Histone deacetylase inhibition activates transgene expression from integration-defective lentiviral vectors in dividing and non-dividing cells.

Authors:  Laetitia P L Pelascini; Josephine M Janssen; Manuel A F V Gonçalves
Journal:  Hum Gene Ther       Date:  2012-12-11       Impact factor: 5.695

4.  Efficient transient genetic manipulation in vitro and in vivo by prototype foamy virus-mediated nonviral RNA transfer.

Authors:  Martin V Hamann; Nicole Stanke; Erik Müllers; Kristin Stirnnagel; Sylvia Hütter; Benedetta Artegiani; Sara Bragado Alonso; Federico Calegari; Dirk Lindemann
Journal:  Mol Ther       Date:  2014-05-12       Impact factor: 11.454

5.  Silent IL2RG Gene Editing in Human Pluripotent Stem Cells.

Authors:  Li B Li; Chao Ma; Geneve Awong; Marion Kennedy; German Gornalusse; Gordon Keller; Dan S Kaufman; David W Russell
Journal:  Mol Ther       Date:  2015-10-07       Impact factor: 11.454

Review 6.  Foamy virus biology and its application for vector development.

Authors:  Dirk Lindemann; Axel Rethwilm
Journal:  Viruses       Date:  2011-05-11       Impact factor: 5.048

Review 7.  The role of unintegrated DNA in HIV infection.

Authors:  Richard D Sloan; Mark A Wainberg
Journal:  Retrovirology       Date:  2011-07-01       Impact factor: 4.602

8.  TraFo-CRISPR: Enhanced Genome Engineering by Transient Foamy Virus Vector-Mediated Delivery of CRISPR/Cas9 Components.

Authors:  Fabian Lindel; Carolin R Dodt; Niklas Weidner; Monique Noll; Fabian Bergemann; Rayk Behrendt; Sarah Fischer; Josephine Dietrich; Marc Cartellieri; Martin V Hamann; Dirk Lindemann
Journal:  Mol Ther Nucleic Acids       Date:  2019-10-17       Impact factor: 8.886

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.